InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Snider Lindy, Director. Director active across 1 company, notably Nexien Biopharma, INC.. Aggregated, 2 reports have been logged. Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Snider Lindy is a Board Member at NEXIEN BIOPHARMA, INC. He is involved in the leadership of the company, bringing his expertise to guide strategic initiatives and ensure regulatory compliance.